ArticleTherapeutic advances in neurological disorders2025
Open-label study of efgartigimod in seronegative myasthenia gravis.
Mohamed Khateb et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it